Perritt Capital Management’s Alimera Sciences ALIM Stock Holding History

Perritt Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$31K	–	358
2023 Q3	$31K	Hold	10,000	–	–	0.02%	233
2023 Q2	$29.2K	Sell	10,000 -8,000	-44%	-$18.4K	0.02%	241
2023 Q1	$37.8K	Hold	18,000	–	–	0.02%	231
2022 Q4	$48.8K	Hold	18,000	–	–	0.03%	227
2022 Q3	$91K	Sell	18,000 -9,400	-34%	-$57.2K	0.06%	176
2022 Q2	$150K	Buy	27,400 +7,400	+37%	+$40.7K	0.09%	158
2022 Q1	$112K	Hold	20,000	–	–	0.06%	186
2021 Q4	$103K	Hold	20,000	–	–	0.05%	195
2021 Q3	$84K	Hold	20,000	–	–	0.05%	191
2021 Q2	$182K	Hold	20,000	–	–	0.1%	184
2021 Q1	$192K	Buy	+20,000	New	+$164K	0.1%	170

Other funds holding ALIM

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Perritt Capital Management's ALIM Position: Q4 2023 in Review

Perritt Capital Management sold out of Alimera Sciences (ALIM) in Q4 2023, closing a stake of 10,000 shares — an estimated $31K sold.

Perritt Capital Management first reported a position in ALIM in Q1 2021 and held it in 11 quarters. The position peaked at $192K in Q1 2021. 35 funds tracked by Wall St. Rank hold ALIM as of Q4 2023.

Perritt Capital Management reported no remaining Alimera Sciences position as of Q4 2023 after selling out during the quarter.
Perritt Capital Management sold 10,000 Alimera Sciences shares in Q4 2023, an estimated $31K.
Perritt Capital Management first reported a position in Alimera Sciences in Q1 2021 and held it in 11 quarters.
Perritt Capital Management's Alimera Sciences position peaked at $192K in Q1 2021.
35 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2023.

Based on Perritt Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.